These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses. Serrano-Rodríguez JM, Gómez-Díez M, Esgueva M, Castejón-Riber C, Mena-Bravo A, Priego-Capote F, Ayala N, Caballero JMS, Muñoz A. Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693 [Abstract] [Full Text] [Related]
31. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. Ninahuaman MF, Souccar C, Lapa AJ, Lima-Landman MT. Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647 [Abstract] [Full Text] [Related]
32. Arterial and endocrine effects of a combination of an angiotensin converting enzyme inhibitor and a vasodilator in normotensive healthy volunteers. Brunel P, Guyene TT, Howald H, Ménard J. J Cardiovasc Pharmacol; 1991 Aug; 18(2):175-81. PubMed ID: 1717776 [Abstract] [Full Text] [Related]
33. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers. Anderson PJ, Critchley JA, Tomlinson B, Resplandy G. Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141 [Abstract] [Full Text] [Related]
34. Modulation of acute transient exercise-induced hypertension after oral administration of four angiotensin-converting enzyme inhibitors in normotensive horses. Muñoz A, Esgueva M, Gómez-Díez M, Serrano-Caballero JM, Castejón-Riber C, Serrano-Rodríguez JM. Vet J; 2016 Feb; 208():33-7. PubMed ID: 26626097 [Abstract] [Full Text] [Related]
35. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis. Tsai HH, Lees KR, Howden CW, Reid JL. Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045 [Abstract] [Full Text] [Related]
37. Pharmacokinetics of M100240 and MDL 100,173, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy young and elderly volunteers. Emmons GT, Argenti R, Martin LL, Martin NE, Jensen BK. J Clin Pharmacol; 2004 Aug; 44(8):901-5. PubMed ID: 15286094 [Abstract] [Full Text] [Related]
38. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects. Stockis A, De Bruyn S, Gengler C, Goethals F, Lens S, Poli G, Acerbi D. Arzneimittelforschung; 2003 Aug; 53(8):554-61. PubMed ID: 13677245 [Abstract] [Full Text] [Related]
40. The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride. Kaiser G, Ackermann R, Gschwind HP, James IM, Sprengers D, McIntyre N, Defalco A, Holmes IB. Biopharm Drug Dispos; 1990 Dec; 11(9):753-64. PubMed ID: 2271751 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]